Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma
This study is currently recruiting participants.
Study NCT00589875   Information provided by Advantagene, Inc.
First Received: December 27, 2007   Last Updated: October 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malignant Glioma
Glioblastoma Multiforme
Anaplastic Astrocytoma
Additional conditions recognized in this trial
Astrocytoma
Glioblastoma
Glioma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Interventions listed in this trial
AdV-tk
Valacyclovir
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Advantagene, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services